Revvity (RVTY) Projected to Post Quarterly Earnings on Monday

Key Points

• Revvity (NYSE:RVTY) is set to announce its Q3 2025 earnings on October 27th, with analysts expecting earnings of $1.14 per share and revenue of $699.747 million.
• The company recently declared a dividend of $0.07 per share, payable on November 7th, reflecting a dividend yield of 0.3%.
• Revvity's stock currently has an average rating of "Moderate Buy" with a consensus target price of $116.62, after recent target adjustments from various research firms.

Revvity (NYSE:RVTY - Get Free Report) is expected to be announcing its Q3 2025 results before the market opens on Monday, October 27th. Analysts expect the company to announce earnings of $1.14 per share and revenue of $699.7470 million for the quarter. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS.Parties are encouraged to explore the company's upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Monday, October 27, 2025 at 8:00 AM ET.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. The company had revenue of $720.28 million during the quarter, compared to the consensus estimate of $711.26 million. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The firm's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.22 EPS. On average, analysts expect Revvity to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Revvity Price Performance

Shares of RVTY opened at $93.60 on Monday. The company has a market cap of $10.86 billion, a price-to-earnings ratio of 39.66, a PEG ratio of 3.12 and a beta of 0.98. The company has a current ratio of 3.33, a quick ratio of 2.75 and a debt-to-equity ratio of 0.43. The company's fifty day simple moving average is $88.59 and its 200 day simple moving average is $92.30. Revvity has a 1-year low of $81.36 and a 1-year high of $129.50.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity's dividend payout ratio (DPR) is presently 11.86%.

Analysts Set New Price Targets

Several research firms have issued reports on RVTY. Guggenheim began coverage on Revvity in a research note on Wednesday. They issued a "neutral" rating on the stock. Stifel Nicolaus dropped their price target on Revvity from $120.00 to $110.00 and set a "hold" rating on the stock in a research note on Tuesday, July 29th. Evercore ISI reduced their price objective on shares of Revvity from $108.00 to $106.00 and set an "outperform" rating for the company in a research report on Tuesday, October 7th. Bank of America decreased their price objective on shares of Revvity from $110.00 to $99.00 and set a "buy" rating on the stock in a report on Monday, September 22nd. Finally, Barclays cut their target price on shares of Revvity from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Thursday, October 2nd. Nine equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $116.62.

Hedge Funds Weigh In On Revvity

Institutional investors and hedge funds have recently modified their holdings of the business. AQR Capital Management LLC raised its stake in Revvity by 5.2% in the 1st quarter. AQR Capital Management LLC now owns 8,449 shares of the company's stock worth $883,000 after purchasing an additional 420 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Revvity by 6.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company's stock worth $1,246,000 after purchasing an additional 744 shares during the period. Millennium Management LLC raised its position in shares of Revvity by 102.0% in the first quarter. Millennium Management LLC now owns 69,401 shares of the company's stock valued at $7,343,000 after buying an additional 35,048 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Revvity by 45.5% in the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company's stock valued at $64,232,000 after buying an additional 189,871 shares during the period. Finally, Focus Partners Wealth boosted its stake in shares of Revvity by 13.0% in the first quarter. Focus Partners Wealth now owns 7,028 shares of the company's stock valued at $744,000 after buying an additional 811 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.